[ACE gene polymorphism in patients with ischemic brain disease]

Area of Science:

• Genetics
• Cardiovascular Medicine
• Neurology

Context:

• Atherothrombotic ischemic stroke is a major cause of disability and mortality.
• The role of the angiotensine converting enzyme (ACE) gene in stroke development requires further elucidation.
• Genetic predisposition to cerebrovascular disease is a significant area of research.

Purpose:

• To investigate the association between the insertion-deletion (I/D) polymorphism of the ACE gene and the risk of developing atherothrombotic ischemic stroke.
• To analyze the correlation between ACE gene polymorphism and risk factors such as arterial hypertension and type II diabetes mellitus.
• To determine if ACE gene polymorphism is linked to hemodynamically significant stenosis in patients with cerebrovascular disease.

Summary:

• This study analyzed ACE gene polymorphism in 153 patients with cerebrovascular disease, including those with atherothrombotic ischemic stroke and chronic cerebrovascular disease without stroke history.
• No significant differences in ACE gene allele or genotype frequencies were found between patient groups or in relation to hypertension and diabetes.
• However, the D/D genotype of the ACE gene was found to significantly predominate in patients with hemodynamically significant stenosis (over 70%).

Impact:

• The findings suggest that while ACE gene polymorphism may not be a direct risk factor for atherothrombotic ischemic stroke overall, it could be associated with the severity of cerebrovascular disease, particularly in the presence of significant stenosis.
• This research contributes to understanding the genetic underpinnings of cerebrovascular disease and may inform future genetic risk assessments.
• Further research is warranted to explore the specific mechanisms linking ACE gene polymorphism to stenosis and stroke development.